Development of RelB-targeting small-molecule inhibitors of non-canonical NF-κB signaling with antitumor efficacy

Cuifeng Li(Shanghai Institute of Nutrition and Health), Xiaoren Zhang(Shanghai Institute of Nutrition and Health)
Molecular Therapy
February 4, 2025
Cited by 9


Related Papers